Dyno Therapeutics is a biotechnology company based in Cambridge, Massachusetts, pioneering the use of artificial intelligence (AI) to revolutionize gene therapy. Founded in 2018 by Eric Kelsic, Ph.D.,Sam Sinai & Alan Crane, Dyno focuses on designing optimized adeno-associated virus (AAV) vectors to enhance the delivery of gene therapies.​